Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

CureVac (CVAC) Equity Ratio (2019 - 2024)

Historic Equity Ratio for CureVac (CVAC) over the last 6 years, with Q4 2024 value amounting to 0.87.

  • CureVac's Equity Ratio rose 3230.89% to 0.87 in Q4 2024 from the same period last year, while for Dec 2024 it was 0.87, marking a year-over-year increase of 3230.89%. This contributed to the annual value of 0.87 for FY2024, which is 3230.89% up from last year.
  • As of Q4 2024, CureVac's Equity Ratio stood at 0.87, which was up 3230.89% from 0.66 recorded in Q4 2023.
  • Over the past 5 years, CureVac's Equity Ratio peaked at 0.87 during Q4 2024, and registered a low of 0.47 during Q4 2020.
  • Its 5-year average for Equity Ratio is 0.64, with a median of 0.62 in 2022.
  • In the last 5 years, CureVac's Equity Ratio surged by 24363.5% in 2020 and then surged by 425.74% in 2022.
  • Quarter analysis of 5 years shows CureVac's Equity Ratio stood at 0.47 in 2020, then increased by 26.29% to 0.59 in 2021, then grew by 4.26% to 0.62 in 2022, then rose by 5.82% to 0.66 in 2023, then surged by 32.31% to 0.87 in 2024.
  • Its Equity Ratio was 0.87 in Q4 2024, compared to 0.66 in Q4 2023 and 0.62 in Q4 2022.